Such results suggest a role of GC and GRs transduction pathways in mood disorders including depression, as the disease is characterized by the increased activity of immune/inflammatory pathways [8], disturbed cognition [9] and synaptic plasticity [10]. The gene discussed is BCL2A1; the disease is major depressive disorder.